Back to School: How biopharma can reboot drug development. Access exclusive analysis here

Millennium, Kyowa Hakko Kogyo Co. Ltd., MorphoSys deal

MLNM extended for a year, through 2001, a 1997 deal with Kyowa to develop treatments for

Read the full 162 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE